Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_48h.class.cls #double_gel_8d_versus_double_gel_48h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_48h_repos |
Upregulated in class | double_gel_8d |
GeneSet | GERY_CEBP_TARGETS |
Enrichment Score (ES) | 0.6124468 |
Normalized Enrichment Score (NES) | 2.1580236 |
Nominal p-value | 0.0 |
FDR q-value | 6.881224E-4 |
FWER p-Value | 0.01 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | FOS | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 9 | 0.936 | 0.0657 | Yes |
2 | RGS2 | RGS2 Entrez,  Source | regulator of G-protein signalling 2, 24kDa | 25 | 0.771 | 0.1192 | Yes |
3 | PROCR | PROCR Entrez,  Source | protein C receptor, endothelial (EPCR) | 37 | 0.690 | 0.1673 | Yes |
4 | DBP | DBP Entrez,  Source | D site of albumin promoter (albumin D-box) binding protein | 41 | 0.688 | 0.2158 | Yes |
5 | LPL | LPL Entrez,  Source | lipoprotein lipase | 45 | 0.671 | 0.2631 | Yes |
6 | RGS16 | RGS16 Entrez,  Source | regulator of G-protein signalling 16 | 103 | 0.505 | 0.2946 | Yes |
7 | CRYAB | CRYAB Entrez,  Source | crystallin, alpha B | 106 | 0.494 | 0.3294 | Yes |
8 | TNFAIP6 | TNFAIP6 Entrez,  Source | tumor necrosis factor, alpha-induced protein 6 | 116 | 0.483 | 0.3630 | Yes |
9 | PRNP | PRNP Entrez,  Source | prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | 141 | 0.455 | 0.3934 | Yes |
10 | PLAT | PLAT Entrez,  Source | plasminogen activator, tissue | 230 | 0.365 | 0.4126 | Yes |
11 | PEA15 | PEA15 Entrez,  Source | phosphoprotein enriched in astrocytes 15 | 279 | 0.322 | 0.4318 | Yes |
12 | ATF3 | ATF3 Entrez,  Source | activating transcription factor 3 | 310 | 0.299 | 0.4508 | Yes |
13 | KLF4 | KLF4 Entrez,  Source | Kruppel-like factor 4 (gut) | 417 | 0.254 | 0.4608 | Yes |
14 | BAIAP2 | BAIAP2 Entrez,  Source | BAI1-associated protein 2 | 473 | 0.236 | 0.4734 | Yes |
15 | ANGPTL4 | ANGPTL4 Entrez,  Source | angiopoietin-like 4 | 493 | 0.230 | 0.4883 | Yes |
16 | ALDH3A1 | ALDH3A1 Entrez,  Source | aldehyde dehydrogenase 3 family, memberA1 | 517 | 0.223 | 0.5023 | Yes |
17 | ECHS1 | ECHS1 Entrez,  Source | enoyl Coenzyme A hydratase, short chain, 1, mitochondrial | 585 | 0.209 | 0.5121 | Yes |
18 | IGF2 | IGF2 Entrez,  Source | insulin-like growth factor 2 (somatomedin A) | 682 | 0.188 | 0.5182 | Yes |
19 | MKNK2 | MKNK2 Entrez,  Source | MAP kinase interacting serine/threonine kinase 2 | 687 | 0.187 | 0.5311 | Yes |
20 | RASL11B | RASL11B Entrez,  Source | RAS-like, family 11, member B | 800 | 0.170 | 0.5347 | Yes |
21 | JUNB | JUNB Entrez,  Source | jun B proto-oncogene | 861 | 0.161 | 0.5416 | Yes |
22 | BTG2 | BTG2 Entrez,  Source | BTG family, member 2 | 880 | 0.159 | 0.5515 | Yes |
23 | DNAJB9 | DNAJB9 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily B, member 9 | 886 | 0.157 | 0.5623 | Yes |
24 | NR1D1 | NR1D1 Entrez,  Source | nuclear receptor subfamily 1, group D, member 1 | 920 | 0.154 | 0.5707 | Yes |
25 | S100A8 | S100A8 Entrez,  Source | S100 calcium binding protein A8 | 960 | 0.151 | 0.5784 | Yes |
26 | IFRD1 | IFRD1 Entrez,  Source | interferon-related developmental regulator 1 | 999 | 0.147 | 0.5860 | Yes |
27 | CXCL1 | CXCL1 Entrez,  Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 1041 | 0.142 | 0.5929 | Yes |
28 | GADD45B | GADD45B Entrez,  Source | growth arrest and DNA-damage-inducible, beta | 1210 | 0.127 | 0.5893 | Yes |
29 | BCKDHB | BCKDHB Entrez,  Source | branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease) | 1252 | 0.124 | 0.5949 | Yes |
30 | DUSP1 | DUSP1 Entrez,  Source | dual specificity phosphatase 1 | 1261 | 0.123 | 0.6030 | Yes |
31 | MAFK | MAFK Entrez,  Source | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 1264 | 0.123 | 0.6115 | Yes |
32 | PER2 | PER2 Entrez,  Source | period homolog 2 (Drosophila) | 1454 | 0.110 | 0.6051 | Yes |
33 | IER2 | IER2 Entrez,  Source | immediate early response 2 | 1461 | 0.110 | 0.6124 | Yes |
34 | ZFAND2A | ZFAND2A Entrez,  Source | zinc finger, AN1-type domain 2A | 1634 | 0.101 | 0.6066 | No |
35 | HBEGF | HBEGF Entrez,  Source | heparin-binding EGF-like growth factor | 1849 | 0.091 | 0.5969 | No |
36 | ACTA2 | ACTA2 Entrez,  Source | actin, alpha 2, smooth muscle, aorta | 2074 | 0.082 | 0.5858 | No |
37 | ACSL1 | ACSL1 Entrez,  Source | acyl-CoA synthetase long-chain family member 1 | 2355 | 0.072 | 0.5698 | No |
38 | FOXG1 | 2441 | 0.070 | 0.5683 | No | ||
39 | APBB1IP | APBB1IP Entrez,  Source | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 2467 | 0.069 | 0.5713 | No |
40 | S100A3 | S100A3 Entrez,  Source | S100 calcium binding protein A3 | 2475 | 0.069 | 0.5757 | No |
41 | SERPINI1 | SERPINI1 Entrez,  Source | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 2621 | 0.064 | 0.5693 | No |
42 | PLAUR | PLAUR Entrez,  Source | plasminogen activator, urokinase receptor | 2983 | 0.055 | 0.5460 | No |
43 | EREG | EREG Entrez,  Source | epiregulin | 3011 | 0.054 | 0.5478 | No |
44 | ABCD2 | ABCD2 Entrez,  Source | ATP-binding cassette, sub-family D (ALD), member 2 | 3159 | 0.051 | 0.5403 | No |
45 | ELOVL6 | ELOVL6 Entrez,  Source | ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) | 3278 | 0.048 | 0.5348 | No |
46 | DCN | DCN Entrez,  Source | decorin | 3405 | 0.045 | 0.5284 | No |
47 | MYD116 | 3627 | 0.040 | 0.5146 | No | ||
48 | CD47 | CD47 Entrez,  Source | CD47 molecule | 3700 | 0.039 | 0.5119 | No |
49 | CLU | CLU Entrez,  Source | clusterin | 3739 | 0.038 | 0.5118 | No |
50 | FGF7 | FGF7 Entrez,  Source | fibroblast growth factor 7 (keratinocyte growth factor) | 4156 | 0.030 | 0.4825 | No |
51 | HP | HP Entrez,  Source | haptoglobin | 4392 | 0.026 | 0.4666 | No |
52 | NRP1 | NRP1 Entrez,  Source | neuropilin 1 | 4730 | 0.020 | 0.4426 | No |
53 | SH3GL3 | SH3GL3 Entrez,  Source | SH3-domain GRB2-like 3 | 4859 | 0.017 | 0.4342 | No |
54 | LCN2 | LCN2 Entrez,  Source | lipocalin 2 (oncogene 24p3) | 5175 | 0.012 | 0.4113 | No |
55 | NSDHL | NSDHL Entrez,  Source | NAD(P) dependent steroid dehydrogenase-like | 5315 | 0.010 | 0.4015 | No |
56 | C3 | C3 Entrez,  Source | complement component 3 | 5333 | 0.010 | 0.4009 | No |
57 | ORM1 | ORM1 Entrez,  Source | orosomucoid 1 | 5348 | 0.009 | 0.4005 | No |
58 | CXCL5 | CXCL5 Entrez,  Source | chemokine (C-X-C motif) ligand 5 | 5599 | 0.006 | 0.3820 | No |
59 | BAG3 | BAG3 Entrez,  Source | BCL2-associated athanogene 3 | 5943 | 0.001 | 0.3562 | No |
60 | CD1D1 | 6037 | -0.000 | 0.3493 | No | ||
61 | RRAD | RRAD Entrez,  Source | Ras-related associated with diabetes | 6316 | -0.005 | 0.3286 | No |
62 | NR2F6 | NR2F6 Entrez,  Source | nuclear receptor subfamily 2, group F, member 6 | 6565 | -0.009 | 0.3105 | No |
63 | ID3 | ID3 Entrez,  Source | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 6682 | -0.010 | 0.3025 | No |
64 | CRABP2 | CRABP2 Entrez,  Source | cellular retinoic acid binding protein 2 | 6879 | -0.013 | 0.2887 | No |
65 | PPARG | PPARG Entrez,  Source | peroxisome proliferative activated receptor, gamma | 7396 | -0.021 | 0.2512 | No |
66 | SERPINB2 | SERPINB2 Entrez,  Source | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 7731 | -0.026 | 0.2279 | No |
67 | FHL2 | FHL2 Entrez,  Source | four and a half LIM domains 2 | 9173 | -0.050 | 0.1228 | No |
68 | XDH | XDH Entrez,  Source | xanthine dehydrogenase | 9455 | -0.055 | 0.1055 | No |
69 | CSPG2 | CSPG2 Entrez,  Source | chondroitin sulfate proteoglycan 2 (versican) | 9690 | -0.060 | 0.0921 | No |
70 | HGF | HGF Entrez,  Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 9857 | -0.063 | 0.0840 | No |
71 | RDH11 | RDH11 Entrez,  Source | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 10402 | -0.075 | 0.0483 | No |
72 | RNH1 | RNH1 Entrez,  Source | ribonuclease/angiogenin inhibitor 1 | 11262 | -0.097 | -0.0096 | No |
73 | LSS | LSS Entrez,  Source | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 11376 | -0.101 | -0.0109 | No |
74 | TRIB3 | TRIB3 Entrez,  Source | tribbles homolog 3 (Drosophila) | 11605 | -0.110 | -0.0204 | No |
75 | ABCA1 | ABCA1 Entrez,  Source | ATP-binding cassette, sub-family A (ABC1), member 1 | 11627 | -0.110 | -0.0141 | No |
76 | GCH1 | GCH1 Entrez,  Source | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 12523 | -0.156 | -0.0706 | No |
77 | PIM1 | PIM1 Entrez,  Source | pim-1 oncogene | 12606 | -0.164 | -0.0652 | No |
78 | CD68 | CD68 Entrez,  Source | CD68 molecule | 12657 | -0.169 | -0.0570 | No |
79 | ID2 | ID2 Entrez,  Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 12777 | -0.181 | -0.0531 | No |
80 | HMOX1 | HMOX1 Entrez,  Source | heme oxygenase (decycling) 1 | 12788 | -0.183 | -0.0409 | No |
81 | MVD | MVD Entrez,  Source | mevalonate (diphospho) decarboxylase | 12932 | -0.205 | -0.0372 | No |
82 | HMGCR | HMGCR Entrez,  Source | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 12984 | -0.215 | -0.0258 | No |
83 | DDIT3 | DDIT3 Entrez,  Source | DNA-damage-inducible transcript 3 | 13182 | -0.289 | -0.0202 | No |
84 | GADD45G | GADD45G Entrez,  Source | growth arrest and DNA-damage-inducible, gamma | 13302 | -0.454 | 0.0030 | No |